Cancer Cell Metabolism Database ~~ Bioinformatics and Systems Medicine Laboratory ~~

Cancer Cell Metabolism Gene Database

Cancer Cell Metabolism Gene DB

Home

	Gene Summary
	Phenotypic Information (metabolism pathway, cancer, disease, phenome)
	Mutations : SVs, CNVs, SNVs
	Gene expression: GE, Protein, DEGE, CNV vs GE
	Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG
	Pharmacological Information: Drug-Gene Network
	Cross referenced IDs

Gene Summary for SLC25A13

Basic gene info.	Gene symbol	SLC25A13
	Gene name	solute carrier family 25 (aspartate/glutamate carrier), member 13
	Synonyms	ARALAR2\|CITRIN\|CTLN2
	Cytomap	UCSC genome browser: 7q21.3
	Genomic location	chr7 :95749531-95951459
	Type of gene	protein-coding
	RefGenes	NM_001160210.1, NM_014251.2,NR_027662.1,
	Ensembl id	ENSG00000004864
	Description	calcium-binding mitochondrial carrier protein Aralar2mitochondrial aspartate glutamate carrier 2solute carrier family 25, member 13 (citrin)
	Modification date	20141222
dbXrefs	MIM : 603859
	HGNC : HGNC
	Ensembl : ENSG00000004864
	HPRD : 04837
	Vega : OTTHUMG00000023074
Protein	UniProt: go to UniProt's Cross Reference DB Table
Expression	CleanEX: HS_SLC25A13
	BioGPS: 10165
	Gene Expression Atlas: ENSG00000004864
	The Human Protein Atlas: ENSG00000004864
Pathway	NCI Pathway Interaction Database: SLC25A13
	KEGG: SLC25A13
	REACTOME: SLC25A13
	ConsensusPathDB
	Pathway Commons: SLC25A13
Metabolism	MetaCyc: SLC25A13
	HUMANCyc: SLC25A13
Regulation	Ensembl's Regulation: ENSG00000004864
	miRBase: chr7 :95,749,531-95,951,459
	TargetScan: NM_001160210
	cisRED: ENSG00000004864
Context	iHOP: SLC25A13
	cancer metabolism search in PubMed: SLC25A13
	UCL Cancer Institute: SLC25A13
Assigned class in ccmGDB	C

Top

Phenotypic Information for SLC25A13(metabolism pathway, cancer, disease, phenome)

Cancer Description
Cancer	CGAP: SLC25A13
	Familial Cancer Database: SLC25A13

* This gene is included in those cancer gene databases.


Oncogene ¹	Tumor Suppressor gene ²	Cancer Gene Census ³	CancerGenes ⁴	Network of Cancer Gene ⁵	Significant driver gene in	Therapeutic Vulnerabilities in Cancer¹

cf) number; DB name
1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/,
3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html,
4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php,
1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/

Metabolic Pathway Description
REACTOME_METABOLISM_OF_PROTEINS REACTOME_METABOLISM_OF_CARBOHYDRATES REACTOME_GLUCOSE_METABOLISM

Others
OMIM
Orphanet
Disease	KEGG Disease: SLC25A13
	MedGen: SLC25A13 (Human Medical Genetics with Condition)
	ClinVar: SLC25A13
Phenotype	MGI: SLC25A13 (International Mouse Phenotyping Consortium)
Phenotype	PhenomicDB: SLC25A13

Mutations for SLC25A13

* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site.

Structural Variants in COSMIC : go to COSMIC mutation histogram

- Statistics for Tissue and Mutation type

Top

- For Inter-chromosomal Variations

There's no inter-chromosomal structural variation.

- For Intra-chromosomal Variations

* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'.

Sample	Symbol_a	Chr_a	Start_a	End_a	Symbol_b	Chr_b	Start_b	End_b
ovary	SLC25A13	chr7	95836073	95836093	CADPS2	chr7	122374949	122374969
pancreas	SLC25A13	chr7	95852908	95852928	FLJ42280	chr7	96126465	96126485

cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract)

Related fusion transcripts : go to Chitars2.0

* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows SLC25A13 related fusion information.

ID	Head Gene						Tail Gene
Accession	Gene_a	qStart_a	qEnd_a	Chromosome_a	tStart_a	tEnd_a	Gene_a	qStart_a	qEnd_a	Chromosome_a	tStart_a	tEnd_a
DA535064	ZNF736	1	221	7	63774311	63774531	SLC25A13	221	551	7	95820517	95838290
BE072029	SLC25A13	1	132	7	95786736	95786868	SLC25A13	127	311	7	95786152	95786336
BI480726	CDK6	12	95	7	92352483	92352566	SLC25A13	87	686	7	95766458	95767055

Other DBs for Structural Variants

Structural Variants in Ensembl: go to Ensembl Structural variation

Structural Variants in dbVar: go to dbVar

Top

Copy Number Variations in COSMIC : go to COSMIC mutation CNV/Expr

Mutation type/ Tissue ID

brca

cns

cerv

endome

haematopo

kidn

Lintest

liver

lung

ovary

pancre

prost

skin

stoma

thyro

urina

Total # sample

GAIN (# sample)

LOSS (# sample)

cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract)

Top

SNV Counts per Each Loci in COSMIC data : go to COSMIC point mutation

: Non-synonymous mutation, : Synonymous mutation, Circle size denotes number of samples.
Maximum mutation count=8

Top

Somatic Mutation Counts per Tissue in COSMIC data

Stat. for Non-Synonymous SNVs (# total SNVs=72)	Stat. for Synonymous SNVs (# total SNVs=24)

Stat. for Deletions (# total SNVs=2)	Stat. for Insertions (# total SNVs=3)

Top

Top 10 SNVs Having the Most Samples in COSMIC data

* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID.

GRCh37 position	Mutation(aa)	Unique sampleID count
chr7:95775866-95775866	p.?	32
chr7:95799433-95799433	p.N412S	7
chr7:95822393-95822393	p.R191C	2
chr7:95818962-95818962	p.K260I	2
chr7:95761164-95761165	p.P495fs*14	2
chr7:95838193-95838193	p.R142K	2
chr7:95775967-95775967	p.I451I	2
chr7:95800820-95800820	p.L398L	2
chr7:95813609-95813609	p.G386D	2
chr7:95838255-95838255	p.I121I	2

Top

SNV Counts per Each Loci in TCGA data

: non-synonymous mutation, : synonymous mutation, Circle size denotes number of samples.
maximum mutation count=7

Point Mutation/ Tissue ID	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20
# sample		6		19	1		2		3	1		7	4			1	9	6	1	13
# mutation		6		13	1		2		3	1		8	4			1	9	9	1	16
nonsynonymous SNV		4		10	1		2		3			6	4				7	7	1	12
synonymous SNV		2		3						1		2				1	2	2		4

cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma])

Top

Top 10 SNVs Having the Most Samples in TCGA data

* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID.

Genomic Position	Mutation(aa)	Unique sampleID count
chr7:95799433	p.N413S,SLC25A13	7
chr7:95820501	p.G650G,SLC25A13	2
chr7:95820524	p.S225L,SLC25A13	2
chr7:95818688	p.F217L,SLC25A13	2
chr7:95750584	p.S426L,SLC25A13	2
chr7:95799394	p.R284H,SLC25A13	2
chr7:95751055	p.E161E,SLC25A13	1
chr7:95814285	p.A499V,SLC25A13	1
chr7:95775897	p.I271I,SLC25A13	1
chr7:95813609	p.A149A,SLC25A13	1

Other DBs for Point Mutations

Point Mutation Table of Ensembl: go to Ensembl variation table

Mutation of cBioPortal: go to cBioPortal's Cross-cancer alteration summary

Copy Number for SLC25A13 in TCGA

* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene.

cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma]

Top

Gene Expression for SLC25A13

Gene Expression in Cancer Cell-lines (CCLE)

* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data.

Differential Gene Expression in Primary Tumors (TCGA)

* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis.
(t test, adjusted p<0.05 (using Benjamini-Hochberg FDR))

Top

CNV vs Gene Expression Plot

* This plots show the correlation between CNV and gene expression.

: Open all plots for all cancer types

Top

Gene-Gene Network Information

Co-Expressed gene's network Plot

* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown.
Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene

: Open all plots for all cancer types


ANLN,ASNS,CENPI,DBF4,DLD,DNAJC2,EML4, IFRD1,KCMF1,NUP205,PNO1,PPP3R1,PSMC2,PUS7, RINT1,SLC25A13,SRPK1,SUV39H2,TRRAP,WDR43,YWHAG	CCDC138,CCDC160,CYP2R1,CYP51A1,F2RL1,GCNT2,IQGAP2, LRRC8D,MANSC1,OAT,PAICS,QTRTD1,RFC3,RFWD3, SEC23B,SLC15A2,SLC25A13,STIL,TMEM87B,XYLB,ZNF138

ANKIB1,ARPC1A,ASL,TMEM243,CBLL1,COG5,CRCP, DDC,DLD,EIF4H,EXOC4,GATAD1,KRIT1,PEX1, POM121,PUS7,SEMA3C,SLC25A13,TNPO3,VKORC1L1,ZSCAN25	ABCD3,ACTR2,MCU,FAR2,GJB2,IQGAP2,ITGB6, LETM1,NDUFS2,NIPA2,PAPSS2,PDCD6IP,PGGT1B,PRSS12, PTBP3,SLC25A13,SLC44A1,TGFA,UGDH,UGT1A10,UGT1A8

Co-Expressed gene's Protein-protein interaction Network Plot

: Open all plots for all cancer types

Top

Interacting Genes (from Pathway Commons)

: Open all interacting genes' information including KEGG pathway for all interacting genes from DAVID

Top

Pharmacological Information for SLC25A13

Cross-referenced pharmacological DB IDs from Uniprot

DB Category

DB Name

DB's ID and Url link

Drug-Gene Interaction Network

* Gene Centered Interaction Network.

* Drug Centered Interaction Network.

DrugBank ID	Target Name	Drug Groups	Generic Name	Drug Centered Network	Drug Structure
DB00128	solute carrier family 25 (aspartate/glutamate carrier), member 13	approved; nutraceutical	L-Aspartic Acid

Top

Cross referenced IDs for SLC25A13

* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section

: Open all cross reference information